Table 4.
Multivariate analysis of Clinicopathological features, tumor markers, and patient survival
| Variable | PFS HR (95% CI) | P value | OS HR (95% CI) | P value |
|---|---|---|---|---|
| ERCC1 (positive vs. negative) | 0.427 (0.211-0.864) | 0.018* | 0.447 (0.219-0.911) | 0.027* |
| BAG-1 (positive vs. negative) | 0.474 (0.257-0.874) | 0.017* | 0.486 (0.262-0.901) | 0.022* |
| Metastasis lymphatics (Yes vs. No) | 0.627 (0.299-1.315) | 0.217 | 0.654 (0.352-1.370) | 0.260 |
| TNM stage (I + II vs. III + IV) | 0.699 (0.336-1.457) | 0.340 | 1.442 (0.691-2.984) | 0.324 |
* represent P < 0.05